Resultados da pesquisa - D Y Kim
- A mostrar 1 - 18 resultados de 18
-
1
-
2
Mutant MotB proteins in Escherichia coli Por David F. Blair, D Y Kim, Howard C. Berg
Publicado em 1991Artigo -
3
-
4
-
5
-
6
-
7
-
8
-
9
Utility of Proton MR Spectroscopy for Differentiating Typical and Atypical Primary Central Nervous System Lymphomas from Tumefactive Demyelinating Lesions Por Shanshan Lu, Sang Joon Kim, Ho Sung Kim, Choong Gon Choi, Young‐Min Lim, E. J. Kim, D. Y. Kim, S. H. Cho
Publicado em 2013Artigo -
10
Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis Por Young Eun Chon, Eun Hee Choi, Kijun Song, Jun Yong Park, D Y Kim, Kwang‐Hyub Han, Chae Yoon Chon, Sang Hoon Ahn, Seung Up Kim
Publicado em 2012Revisão -
11
Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data Por Yasir Qazi, David R. Shaffer, Bruce Kaplan, D.Y. Kim, Fu L. Luan, V.R. Peddi, Fuad S. Shihab, Stephen J. Tomlanovich, S. Yilmaz, Kevin McCague, Dharmesh Patel, S. Mulgaonkar
Publicado em 2016Artigo -
12
CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma? Por W. S. Kim, Si Yeol Song, Yong Chan Ahn, Young Hyeh Ko, Chung‐Hwan Baek, D. Y. Kim, S.-S. Yoon, H. G. Lee, Wonseok Kang, H. J. Lee, C H Park, K. Park
Publicado em 2001Artigo -
13
Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model Por J.-H. Choi, J.-H. Choi, D.-Y. Kim, Jung Hee Yoon, H.-Y. Youn, Jun Yi, H.-I. Rhee, Kyung Hwan Ryu, Kiwon Jung, C.-K. Han, W.-J. Kwak, Y.-B. Cho
Publicado em 2002Artigo -
14
Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea Por Y. S. Kim, S. J. Kim, Jai Hoon Yoon, Ki Tae Suk, J. B. Kim, Dong Joon Kim, D. Y. Kim, Hyun-Jun Min, S. H. Park, Woon Geon Shin, K. H. Kim, H. Y. Kim, Gwang Ho Baik
Publicado em 2011Artigo -
15
The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery Por Young Ho Yun, Y.A. Kim, Ye Min, S. Park, Young‐Joo Won, D. Y. Kim, Il Ju Choi, Young‐Woo Kim, S. J. Park, J.H. Kim, D. H. Lee, Seok‐Jun Yoon, Seung‐Yong Jeong, Dong‐Young Noh, D.S. Heo
Publicado em 2012Artigo -
16
Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study Por S.-E. Lee, Soo Young Choi, Ho Young Song, S H Kim, M.-Y. Choi, J. S. Park, H.-J. Kim, S.-H. Kim, Dae Young Zang, Subi Oh, H. Kim, Y. R., Jae‐Yong Kwak, Jeong‐Ah Kim, D.-Y. Kim, Yeung‐Chul Mun, W. S. Lee, Myung Hee Chang, Jinny Park, J. H. Kwon, D.-W. Kim
Publicado em 2016Artigo -
17
Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view Por D.H. Lim, D Y Kim, Minyong Kang, Y I Kim, Won Ki Kang, C K Park, S Kim, Jung Hyun Noh, Jae‐Won Joh, Seong Ho Choi, Tae Sung Sohn, Jin Seok Heo, C. H. Park, J O Park, Jeong Eun Lee, Y J Park, Hae-Seon Nam, Wonse Park, Yong Chan Ahn, Seung Jae Huh
Publicado em 2004Artigo -
18
Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors Por S.-H. Kim, Hari Menon, Saengsuree Jootar, T Saikia, J. Kwak, S.K. Sohn, J. S. Park, Seong Hyun Jeong, Hyung‐Jun Kim, Y.-K. Kim, Subi Oh, Heonoh Kim, Dae Young Zang, Joo-Seop Chung, Hyeon Ju Shin, Yashwant Lamture, Jeong‐Ah Kim, D.-Y. Kim, Chul Won Choi, Sung Sup Park, H. L. Park, G. Y. Lee, Dongwook Cho, Jae‐Soo Shin, D.-W. Kim
Publicado em 2014Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Medicine
Internal medicine
Biology
Gastroenterology
Surgery
Gene
Oncology
Biochemistry
Cancer
Chemotherapy
Immunology
Physics
Adjuvant
Cell biology
Cohort
Confidence interval
Environmental health
Gene expression
Genetics
Imatinib
Imatinib mesylate
Incidence (geometry)
Lymphoma
Multivariate analysis
Myeloid leukemia
Optics
Pathology
Pharmacology
Population
Radiation therapy